Abstract
Background
Flow‐mediated dilatation (FMD) of the brachial artery is a method capable of detecting endothelium dysfunction. Statins are generally consent drugs for reducing cardiovascular morbidity and mortality and are shown to improve the systemic endothelial function.
Hypothesis
The aim of our study was to assess the endothelial function using FMD of the brachial artery in patients with different degrees of coronary artery stenosis with respect to their treatment with statins.
Methods
We evaluated the FMD of 221 patients with coronary arteriography performed, of whom 99 (44.8%) were receiving statins and 122 (55.2%) were not receiving statins.
Results
We did not find a statistically significant difference in the FMD values between the patients with and without a statin treatment: 5.57 ± 5.68 and 4.69 ± 4.48, respectively, P = .581. In the subgroup of patients without angiographically visible coronary artery stenoses or with stenoses <20% (86 patients), patients undergoing statin treatment had a significantly better endothelial function compared to patients without such a treatment: FMD 9.24 ± 6.87 and 6.50 ± 4.51, respectively, P = .047.
Conclusions
FMD could not distinguish between the patients who were treated with statin and those not treated with statins with the same demographic, clinical, and angiographic characteristics. The only exception was in the group of patients with a minor coronary disease. Statin treatment had a more pronounced effect in the earlier stages of coronary atherosclerosis. Copyright © 2009 Wiley Periodicals, Inc.
Full Text
The Full Text of this article is available as a PDF (269.4 KB).
References
- 1. Celermajer DS, Sorensen KE, Gooch VM, et al. Non‐invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992; 340: 1111–1115. [DOI] [PubMed] [Google Scholar]
- 2. Scandinavian Simvastatin Survival Study Group . Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994; 344: 1383–1389. [PubMed] [Google Scholar]
- 3. Jarvisalo MJ, Toikka JO, Vasankari T, et al. HMG CoA reductase inhibitors are related to improved systemic endothelial function in coronary artery disease. Atherosclerosis. 1999; 147: 237–242. [DOI] [PubMed] [Google Scholar]
- 4. De Backer G, Ambrosioni E, Borch‐Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). Eur J Cardiovasc Prev Rehabil. 2003; 10: S1–S78. [DOI] [PubMed] [Google Scholar]
- 5. Corretti M, Anderson T, Benjamin E, et al. Guidelines for the ultrasound assessment of endothelial‐dependent flow‐mediated vasodilation of the brachial artery. A report of the international brachial artery reactivity task force. J Am Coll Cardiol. 2002; 39: 257–265. [DOI] [PubMed] [Google Scholar]
- 6. Simova I, Nossikov A, Denchev S. Interobserver and intraobserver variability of flow mediated vasodilatation of the brachial artery. Echocardiography. 2008; 25: 77–83. [DOI] [PubMed] [Google Scholar]
- 7. Pearson TA, Laurora I, Chu H, Kafonek S. The lipid treatment assessment project (L‐TAP): a multicentre study to evaluate the percentages of dyslipidemic patients receiving lipid‐lowering therapy and achieving low‐density lipoprotein cholesterol goals. Arch Intern Med. 2000; 160: 459–467. [DOI] [PubMed] [Google Scholar]
- 8. Expert Panel on Detection, Evaluation, and Treatment High Blood Cholesterol in Adults . Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment high blood cholesterol in adults (adult treatment panel III). JAMA. 2001; 285: 2486–2497. [DOI] [PubMed] [Google Scholar]
- 9. EUROASPIRE II Study Group . Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme. Eur Heart J. 2001; 22: 554–572. [DOI] [PubMed] [Google Scholar]
- 10. Vogel RA, Nissen AE, Weiss RJ. Endothelial function, low‐density lipoprotein, and moderate and intensive cholesterol lowering in coronary artery disease: a REVERSAL trial substudy. J Am Coll Cardiol. 2005; 45: 412A, Abstract 831–836.15680721 [Google Scholar]